Literature DB >> 18830715

Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis.

Hajime Yamazaki1, Kandai Nozu, Ichiei Narita, Michio Nagata, Yoshimi Nozu, Xue Jun Fu, Masafumi Matsuo, Kazumoto Iijima, Fumitake Gejyo.   

Abstract

Type I Bartter syndrome (BS) is caused by mutations of the Na-K-2Cl cotransporter (NKCC2)-encoding SLC12A1 gene. The clinical phenotype of this severe form of BS is characterized by polyhydramnios, premature delivery, failure to thrive, and nephrocalcinosis, and the diagnosis is usually made during the antenatal-neonatal period. This report concerns a 29-year-old Japanese man with atypical type I BS due to a compound heterozygous mutation of the SLC12A1 gene. He was born after full-term pregnancy complicated by polyhydramnios. He first presented with asymptomatic proteinuria at the age of 20 years and was diagnosed with BS based on laboratory data. There were signs of moderate proteinuria, mild renal dysfunction and nephrocalcinosis. Renal biopsy showed focal segmental glomerulosclerosis (FSGS), and genetic testing revealed novel mutations of A555V and G809V in the SLC12A1 gene. The patient's sister showed the same clinical course, laboratory test abnormalities and gene mutations. Our patient had a type I BS with an atypical clinical course, which was diagnosed when he was 20 years old. Laboratory findings indicated phenotypic variability in this disease, and the presence of nephropathy suggested that FSGS might be one of the lesions causing end-stage renal failure in this disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18830715     DOI: 10.1007/s00467-008-0999-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

1.  Progression and potential regression of glomerulosclerosis.

Authors:  A B Fogo
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

2.  Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III.

Authors:  D B Simon; R S Bindra; T A Mansfield; C Nelson-Williams; E Mendonca; R Stone; S Schurman; A Nayir; H Alpay; A Bakkaloglu; J Rodriguez-Soriano; J M Morales; S A Sanjad; C M Taylor; D Pilz; A Brem; H Trachtman; W Griswold; G A Richard; E John; R P Lifton
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

3.  Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK.

Authors:  D B Simon; F E Karet; J Rodriguez-Soriano; J H Hamdan; A DiPietro; H Trachtman; S A Sanjad; R P Lifton
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

4.  Late-onset manifestation of antenatal Bartter syndrome as a result of residual function of the mutated renal Na+-K+-2Cl- co-transporter.

Authors:  Carsten A Pressler; Jolanta Heinzinger; Nikola Jeck; Petra Waldegger; Ulla Pechmann; Stephan Reinalter; Martin Konrad; Rolf Beetz; Hannsjörg W Seyberth; Siegfried Waldegger
Journal:  J Am Soc Nephrol       Date:  2006-06-28       Impact factor: 10.121

5.  C1q nephropathy in association with Gitelman syndrome: a case report.

Authors:  Coral Hanevold; Ayesa Mian; Rory Dalton
Journal:  Pediatr Nephrol       Date:  2006-09-06       Impact factor: 3.714

Review 6.  Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts).

Authors:  V D D'Agati
Journal:  Kidney Int       Date:  2007-11-07       Impact factor: 10.612

7.  Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2.

Authors:  D B Simon; F E Karet; J M Hamdan; A DiPietro; S A Sanjad; R P Lifton
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

8.  Non-steroidal anti-inflammatory drug-associated nephrotoxicity in Bartter syndrome.

Authors:  A D Schachter; G S Arbus; R J Alexander; J W Balfe
Journal:  Pediatr Nephrol       Date:  1998-11       Impact factor: 3.714

9.  Reversal of Bartter's syndrome by renal transplantation in a child with focal, segmental glomerular sclerosis.

Authors:  S L Blethen; J J Van Wyk; W B Lorentz; J C Jennette
Journal:  Am J Med Sci       Date:  1985-01       Impact factor: 2.378

10.  Phenotypic variability in Bartter syndrome type I.

Authors:  A Bettinelli; S Ciarmatori; L Cesareo; S Tedeschi; G Ruffa; A C Appiani; A Rosini; G Grumieri; B Mercuri; M Sacco; G Leozappa; S Binda; M Cecconi; C Navone; C Curcio; M L Syren; G Casari
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

View more
  15 in total

1.  A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5.

Authors:  Takayuki Okamoto; Toshihiro Tajima; Tomoya Hirayama; Satoshi Sasaki
Journal:  Eur J Pediatr       Date:  2011-09-20       Impact factor: 3.183

2.  Focal segmental glomerulosclerosis in a boy with Dent-2 disease.

Authors:  Kazunari Kaneko; Masafumi Hasui; Atsuko Hata; Daisuke Hata; Kandai Nozu
Journal:  Pediatr Nephrol       Date:  2009-11-10       Impact factor: 3.714

Review 3.  The long-term complications of the inherited tubulopathies: an adult perspective.

Authors:  Maryam Khosravi; Stephen B Walsh
Journal:  Pediatr Nephrol       Date:  2014-02-25       Impact factor: 3.714

4.  A patient with Bartter syndrome accompanying severe growth hormone deficiency and focal segmental glomerulosclerosis.

Authors:  Ipek Akil; Serkan Ozen; Ali Riza Kandiloglu; Betul Ersoy
Journal:  Clin Exp Nephrol       Date:  2010-02-04       Impact factor: 2.801

5.  Renal transplantation in a patient with Bartter syndrome and glomerulosclerosis.

Authors:  Se Eun Lee; Kyoung Hee Han; Yun Hye Jung; Hyun Kyung Lee; Hee Gyung Kang; Kyung Chul Moon; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Korean J Pediatr       Date:  2011-01-31

6.  A case of Bartter syndrome type I with atypical presentations.

Authors:  Eun Hye Lee; Ju Sun Heo; Hyun Kyung Lee; Kyung Hee Han; Hee Gyung Kang; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Korean J Pediatr       Date:  2010-08-31

7.  Primary molecular disorders and secondary biological adaptations in bartter syndrome.

Authors:  Georges Deschênes; Marc Fila
Journal:  Int J Nephrol       Date:  2011-09-20

8.  Xenopus as a model system for the study of GOLPH2/GP73 function: Xenopus GOLPH2 is required for pronephros development.

Authors:  Leike Li; Luan Wen; Yu Gong; Guoqiang Mei; Jinsong Liu; Yonglong Chen; Tao Peng
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

9.  Two novel mutations in the CLCNKB gene leading to classic Bartter syndrome presenting as syncope and hypertension in a 13-year-old boy.

Authors:  Binh T Le; Cuong M Duong; Tien Q Nguyen; Chi-Bao Bui
Journal:  BMJ Case Rep       Date:  2020-07-05

10.  Standardized, systemic phenotypic analysis of Slc12a1I299F mutant mice.

Authors:  Elisabeth Kemter; Birgit Rathkolb; Lore Becker; Ines Bolle; Dirk H Busch; Claudia Dalke; Ralf Elvert; Jack Favor; Jochen Graw; Wolfgang Hans; Boris Ivandic; Svetoslav Kalaydjiev; Thomas Klopstock; Ildikó Rácz; Jan Rozman; Anja Schrewe; Holger Schulz; Andreas Zimmer; Helmut Fuchs; Valérie Gailus-Durner; Martin Hrabe de Angelis; Eckhard Wolf; Bernhard Aigner
Journal:  J Biomed Sci       Date:  2014-08-02       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.